Mark E. Saad, Director: Axsome Therapeutics AXSM Sell · Filed 24/09/11

Trade details

Type: Insider sale
Amount: $1,005,870.96
Shares · price: 11,016 sh · $91.31 a share
Held after: 10,002 sh
Stock: Axsome Therapeutics AXSM
Person: Mark E. SaadDirector
Trade date: 24/09/11
Filed: 24/09/11
Days to filing: 0 days

Sold 52.4% of holdings

Share of holding sold: 52.4%

Axsome Therapeutics trades, last 26 weeks

What else happened in Axsome Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/12~24/10/11

Mark E. Saad's recent trades

Mark E. SaadDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$5.2M
31,346 sh
$5.2M
Filed 01/02
Traded 25/12/31
Mark E. SaadDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1M
6,231 sh
$1M
Filed 01/02
Traded 25/12/31
Mark E. SaadDirector
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$6.2M
37,577 sh
$6.2M
Filed 25/12/31
Traded 25/12/31
Mark E. SaadDirector
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 plan
Axsome Therapeutics
AXSM
$1.1M
9,127 sh
$1.1M
Filed 25/09/05
Traded 25/09/05
Mark E. SaadDirector
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 plan
Axsome Therapeutics
AXSM
$1.1M
9,127 sh
$1.1M
Filed 25/09/05
Traded 25/09/05